Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 19 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
DE VOS PHARMA from Balen, company number BE0809148066, closed financial year 2025 with a result of € 92,384 after tax. For that financial year DE VOS PHARMA recorded a gross margin of € 185,295 and equity of € 866,025. Compared with financial year 2024, the result moved from € 50,113 to € 92,384. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.
€ 866,025
▲ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 92,384
▲ 84% vs 2024
Profit after tax over the fiscal year.
€ 15,157
▲ 23% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 859,825.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 1,683
▼ 86% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 714,279
▼ 5% vs 2024
€ 93,033 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 2,533
▲ 75% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 37,066
▲ 204% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 77,149 | € 114,020 | € 134,533 | € 185,295 | ▲ 38% |
| Profit after taxes | € 23,164 | € 44,666 | € 50,113 | € 92,384 | ▲ 84% |
| Equity | € 678,861 | € 723,527 | € 773,641 | € 866,025 | ▲ 12% |
| Total debts | € 1,234,393 | € 1,226,492 | € 1,136,565 | € 1,129,674 | ▼ 1% |
| Cash | € 30,122 | € 34,210 | € 12,347 | € 15,157 | ▲ 23% |
| Retained profit | € 672,661 | € 717,327 | € 767,441 | € 859,825 | ▲ 12% |
| Bank debt | € 841,054 | € 827,032 | € 753,441 | € 714,279 | ▼ 5% |
| Balance sheet total | € 1,913,254 | € 1,950,019 | € 1,910,205 | € 1,995,699 | ▲ 4% |
Key figures of DE VOS PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DE VOS PHARMA?
What happened at DE VOS PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 92,384 (▲ 84% vs 2024). Source: NBB ↗
- DGI CONSULTING BV became a director. NBB
- New establishment in Balen. KBO
- Start of the company according to the CBE. KBO
- Ilse De Vos became a director. NBB
In short
From € 23,164 profit in 2022 to € 92,384 profit in 2025.
Paid € 87,257 in corporate taxes since 2022.
Best year ever: 2025, with € 92,384 profit.
Management
Behind DE VOS PHARMA are Ilse De Vos and DGI CONSULTING BV. It owns 100% of De Vos Apotheek itself.
Directors
According to the 2025 annual accounts
since 2009
Director · represented by Davy Gielen
since 2016
Establishments
Establishment units
Physical locations of this company
Veldstraat 43
2491 Balen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0809.148.066
- VAT number
- BE 0809.148.066
- Registered office
- Veldstraat 43, 2491 Balen
- Names & denominations
- DE VOS PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 January 2009
- Peppol
- Active · Active since 14 Oct 2025
- Activities · NACE
Detailhandel in farmaceutische producten